- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2026 | 14.92M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 14.92M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 14.92M sh |
| Capex | FY 2025 · Dec 31, 2025 | $13K |
| Capex | FY 2025 · Dec 31, 2024 | $46K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$766K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$15.67M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $1.01M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $81K |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $27.36M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $32.96M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $41.6M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $68.57M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $63.9M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $71.71M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $68.93M |
| Current Assets | FY 2025 · Dec 31, 2025 | $44.17M |
| Current Assets | FY 2025 · Dec 31, 2024 | $44.76M |
| Total Assets | FY 2025 · Dec 31, 2025 | $99.07M |
| Total Assets | FY 2025 · Dec 31, 2024 | $101.9M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.38 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.58 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.38 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.58 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $5.29M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $6.44M |
| Net Income | FY 2025 · Dec 31, 2025 | −$5.6M |
| Net Income | FY 2025 · Dec 31, 2024 | −$8.64M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$1.52M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$4.31M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $270.71M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $313.63M |
| Revenue | FY 2025 · Dec 31, 2025 | $279.39M |
| Revenue | FY 2025 · Dec 31, 2024 | $317.52M |